CPT 82482 Red Blood Cell Cholinesterase Reimbursement

CPT code 82482 denotes a laboratory assay that quantitatively measures cholinesterase activity in red blood cells, an enzyme critical to nervous system function. The test is clinically relevant for assessing potential exposures to cholinesterase-inhibiting agents and for investigating inherited or acquired enzyme deficiencies. Nationally, reporting and reimbursement for enzymatic assays like this affect clinical toxicology, occupational health, and certain neuromuscular diagnostic pathways.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and common modifier usage patterns for laboratory procedures. The publication summarizes what to expect in billing and documentation for CPT code 82482, highlights where the service is typically performed, and outlines areas where policy updates or payer-specific application may influence claim processing.

The content is intended to inform revenue cycle, laboratory directors, and clinical billing staff about the code's clinical purpose, how it is commonly used in practice, and which payers are typically involved. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 82482 measures the level of cholinesterase in red blood cells from a patient specimen. This test assesses an important enzyme involved in nervous system function and is typically ordered when exposure to certain toxins or suspected enzyme deficiency is being evaluated.

Service Type: Laboratory test — quantitative enzymatic assay

Typical Site of Service: Clinical laboratory or hospital laboratory (inpatient or outpatient specimen collection and testing)

Clinical Context

A 35-year-old agricultural worker presents to the occupational health clinic after possible exposure to organophosphate pesticides with symptoms of muscle weakness, increased salivation, headache, and miosis. The clinician collects a blood specimen and orders red blood cell cholinesterase testing to assess for cholinesterase inhibition consistent with organophosphate or carbamate poisoning. The laboratory receives the specimen, performs specimen accessioning, prepares erythrocyte lysate, and measures erythrocyte (red blood cell) cholinesterase activity using an enzymatic assay. Results are reported to the ordering clinician to guide acute management, confirm exposure, and support workplace exposure investigation or disability determination. Typical site of service is a hospital laboratory or independent clinical laboratory that performs specialized toxicology and enzymatic assays. Specimen handling, proper labeling, and timely transport are part of the clinical workflow; results may influence decontamination, antidotal therapy, and follow-up testing.

Coding Specifications

Modifier	Description	When to Use
`00`	Default / No modifier	Use when no other modifier applies and standard reporting is required
`11`	Office or other outpatient service (default)

Taxonomy Code	Specialty	Notes
207RH0000X	Pathology	Clinical pathologists and laboratory medicine physicians who oversee testing and interpretation
2080P0208X	Clinical Laboratory	Clinical laboratory scientists and directors who perform enzymatic assays and analytic testing
333600000X	Occupational Medicine	Occupational medicine physicians who order testing for workplace exposures and manage follow-up
207L00000X	Anatomic and Clinical Pathology	Physicians with combined training who may order and interpret specialized toxicology tests
207P00000X	Toxicology	Specialists in clinical toxicology involved in interpretation and management notes

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T60.0X1A`	Toxic effect of organophosphate and carbamate insecticide, accidental (unintentional), initial encounter	Direct indication for erythrocyte cholinesterase testing to document enzyme inhibition after organophosphate exposure
`T60.0X2A`	Toxic effect of organophosphate and carbamate insecticide, intentional self-harm, initial encounter	Relevant when testing is required in suspected intentional poisoning to guide treatment and disposition
`T60.0X4A`	Toxic effect of organophosphate and carbamate insecticide, undetermined, initial encounter	Used when intent is unclear; cholinesterase testing aids diagnosis and medicolegal documentation
`T65.891A`	Toxic effect of other insecticides, initial encounter	Broader insecticide exposures where cholinesterase inhibition is a concern and testing is clinically indicated
`Z57.8`	Occupational exposure to other risk factors	Used in workplace exposure assessments where cholinesterase testing supports occupational health management
`R53.1`	Weakness	Symptom code often present in cholinesterase-inhibited patients and may prompt ordering of testing
`G90.8`	Other disorders of the autonomic nervous system	Signs of autonomic dysfunction from cholinesterase inhibition may be coded alongside testing for comprehensive clinical documentation

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Often performed immediately prior to cholinesterase testing to obtain the specimen for analysis
`82542`	Drug assay, qualitative; presumptive, other panel	May be ordered alongside cholinesterase to screen for common toxicants in acute exposures
`80305`	Drug confirmation test, e.g., chromatography, GC/MS, per specimen	Used when confirmation of a suspected toxicologic agent is required in addition to enzyme activity measurement
`81025`	Urinalysis, automated, with microscopy if performed	Performed as part of initial evaluation for exposures and to assess renal status during toxic exposure management
`99000`	Handling and/or conveyance of specimen	Used by some laboratories or facilities to bill for specimen handling or transport related to specialized testing
`0000`	Data not available in the input.

OpenPayer

Summary & Overview

CPT 82482: Red Blood Cell Cholinesterase Measurement